Stock Research for MYL

Current Price


Latest Update: 2018-03-23 16:00:00

$ 38.9600
$ 38.8600
$ 38.8700

Featured Broker: TradeStation

Get the due diligence for another stock.


MYL Stock Chart & Research Data

The MYL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MYL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


MYL Due diligence Resources & Stock Charts

The MYL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MYL Detailed Price Forecast - CNN Money CNN View MYL Detailed Summary - Google Finance
Yahoo View MYL Detailed Summary - Yahoo! Finance Zacks View MYL Stock Research & Analysis -

Stock Analysis

TradeIdeas View MYL Trends & Analysis - Trade-Ideas Barrons View MYL Major Holders - Barrons
NASDAQ View MYL Call Transcripts - NASDAQ Seeking View MYL Breaking News & Analysis - Seeking Alpha
Spotlight View MYL Annual Report - OTC Report View MYL OTC Short Report -
TradeKing View MYL Fundamentals - TradeKing Charts View MYL SEC Filings - Bar Chart
WSJ View Historical Prices for MYL - The WSJ Morningstar View Performance/Total Return for MYL - Morningstar
MarketWatch View the Analyst Estimates for MYL - MarketWatch CNBC View the Earnings History for MYL - CNBC
StockMarketWatch View the MYL Earnings - StockMarketWatch MacroAxis View MYL Buy or Sell Recommendations - MacroAxis
Bullish View the MYL Bullish Patterns - American Bulls Short Pains View MYL Short Pain Metrics -

Social Media Mentions

StockTwits View MYL Stock Mentions - StockTwits PennyStocks View MYL Stock Mentions - PennyStockTweets
Twitter View MYL Stock Mentions - Twitter Invest Hub View MYL Investment Forum News - Investor Hub
Yahoo View MYL Stock Mentions - Yahoo! Message Board Seeking Alpha View MYL Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for MYL - Insider Cow View Insider Transactions for MYL - Insider Cow
CNBC View MYL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MYL - OTC Markets
Yahoo View Insider Transactions for MYL - Yahoo! Finance NASDAQ View Institutional Holdings for MYL - NASDAQ

Stock Charts

FinViz View MYL Stock Insight & Charts - StockCharts View MYL Investment Charts -
BarChart View MYL Stock Overview & Charts - BarChart Trading View View MYL User Generated Charts - Trading View

Latest Financial News for MYL

Top Research Reports for Oracle, Vale & General Mills
Posted on Friday March 23, 2018

Top Research Reports for Oracle, Vale & General Mills

Teva Is Implementing This Strategy as Part of Its Restructuring
Posted on Friday March 23, 2018

In December 2017, Teva Pharmaceutical (TEVA) laid down its restructuring plan, which included R&D (research and development) optimization involving the consolidation of its R&D sites while maintaining a robust R&D portfolio. For more details, read What’s Teva Pharmaceutical’s Research and Development Strategy? Since Teva laid out its restructuring plans, it has cut down 25 of its specialty area projects, representing ~27% of its R&D programs.

Key Updates on Teva’s Restructuring Plan Progress
Posted on Friday March 23, 2018

Investor Update: How Is Teva's Restructuring Plan Progressing? Teva Pharmaceutical (TEVA) announced a restructuring plan in mid-December 2017. The announcement came after the company made some key leadership changes to recuperate from the dismal performance it saw over the last few quarters following its acquisition of Allergan’s (AGN) generics business and the negative impact of increasing generics business competition and pricing pressures.

Discussing Teva’s Recent Stock Performance
Posted on Friday March 23, 2018

On March 20, 2018, Teva Pharmaceutical (TEVA) ended the trading day at a closing price of $17.68. Recently, on February 15, 2018, TEVA stock registered a rise of ~10.5% triggered by the news of an investment of $358 million in the company by Berkshire Hathaway. This news led to the market’s gaining some confidence in the troubled stock, as Berkshire Hathaway investments have been synonymous with value investments.

Warning: DOMDocument::load(): StartTag: invalid element name in, line: 1 in /home/allsites/ on line 494

Warning: DOMDocument::load(): Extra content at the end of the document in, line: 1 in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.